- ROUNDTABLE: Pharmacy’s future in sync with technology
- EXPERT BLOG: Provider status for pharmacists — one way or another
- Study from NCPA sheds new light on med synchronization programs
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- Senate passes Drug Quality and Security Act
NEW YORK Almost one-third of those community pharmacists who already offered DMEPOS services responded that they would cease delivering Medicare services if Congress doesn’t act soon.
That should be a wake-up call for Congress.
The reality is the number of community pharmacies that would no longer supply products like diabetes test strips to their Medicare patients is a lot closer to 90% of all community pharmacies, or approximately 20,000 pharmacies, more or less, given that only one in 10 are currently accredited under Centers for Medicare and Medicaid Services guidelines, the fact that the accreditation deadline is only five months away and it takes on average more than six months to become accredited.
To be sure, the survey is a sample of about 1,000 self-reporting pharmacists and there may be a good number of community pharmacists currently pursuing accreditation not included in the 10%, but the bare fact remains that the vast majority of community pharmacies aren’t accredited and will decline to become accredited come Oct. 1.
What does it all mean? To quote Bruce Roberts, NCPA EVP & CEO, it means “the current policy could prevent patients, especially in underserved areas [such as rural communities], from accessing medical supplies that help navigate health challenges such as controlling diabetes.”
Approximately 17.9% of all Medicare households are located in rural communities, according to a Kaiser Foundation report released in February, which means that almost one in five of all Medicare recipients may have greater difficulty accessing their testing supplies.
And that should be a bigger wake-up call for Congress, as well as their Medicare-eligible constituents.